LncRNA GAS5 was downregulated in cervical cancer tissues, significantly correlated to advanced cancer progression, and identified as a separate biomarker for forecasting the clinical states of patients in cervical cancer [26]; LncRNA TUSC8 was dramatically reduced in cervical cancer and linked to the FIGO stage, size of tumor, and squamous cell carcinoma antigen [27]; LncRNA LET was also observed to be downregulated in cervical tumor. Here, GAS5 is linked to cancer.